The high-stakes litigation over Tylenol and its alleged connection to autism is gaining renewed momentum. Plaintiffs in more than 500 lawsuits that were previously dismissed are urging the 2nd U.S.

Kenvue Inc. (NYSE:KVUE) has been in the news lately after President Trump asserted that taking Tylenol can increase autism in ...

President Donald Trump on Monday used the platform of the presidency to promote unproven and in some cases discredited ties ...

“Don’t take Tylenol,” Trump instructed pregnant women around a dozen times during a White House news conference. He also ...

Tylenol, Kenvue’s biggest product, has been sold over-the-counter in the United States since the 1960s and makes up about 10% of group sales. Rothschild estimated that sales to expectant mothers ...

NEW YORK (AP) — U.S. stock indexes slipped on Tuesday as Wall Street took a pause from its relentless rally. The S&P 500 dipped 0.6%. The Dow Jones Industrial Average dropped 88 points, or 0.2%, and ...

Kenvue (NYSE: KVUE) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...

The deleted tweet from 2017 has raised questions, but major medical groups stress the risks of avoiding acetaminophen are greater ...

Rothschild & Co Redburn analyst Edward Lewis upgraded Kenvue (KVUE) to Buy from Neutral with a price target of $22, down from $22.50. The shares ...

The manufacturer of Tylenol on Thursday clarified an old social media post that said it doesn’t “actually recommend” using ...